{
  "abstract": "Coombes’s report usefully frames the new proposals for medical device regulation from the Medicines and Healthcare Products Regulatory Agency (MHRA) as a patient safety response to a rapidly expanding market in direct-to-consumer self-tests.1 The point that now needs sharper regulatory attention is narrower: when a person buys such a test, the product should make clear who is expected to interpret the result and who carries responsibility for the next step.",
  "authors": [
    {
      "affiliations": [
        "Ganzhou People’s Hospital, Ganzhou, China"
      ],
      "name": "Xiaojuan Wu"
    }
  ],
  "title": "Self-tests need accountable follow-up pathways",
  "uid": "e71dd2e1-798a-55dd-b736-256c979aa948"
}